For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260402:nRSB1556Za&default-theme=true
RNS Number : 1556Z Judges Scientific PLC 02 April 2026
2 April 2026
Judges Scientific plc
("Judges Scientific" or the "Company")
Director/PDMR Shareholding
The Company announces that on 1 April 2026 David Cicurel, Non-Executive Chair,
transferred the beneficial interest in 4,000 ordinary shares of 5 pence each
in the Company ("Ordinary Shares") to the Shoftim Charitable Trust (the
"Charity").
David Cicurel is a trustee of the Charity. Following this gift David Cicurel
is beneficially interested in 547,898 Ordinary Shares and he remains
beneficially and non beneficially interested in 618,898 Ordinary Shares, his
non beneficial interest comprising 71,000 Ordinary Shares he has gifted to the
Charity.
For further information please contact:
Judges Scientific plc Shore Capital (Nominated Adviser & Joint Broker)
David Cicurel, CEO Stephane Auton
Brad Ormsby, CFO Harry Davies-Ball
Tel: +44 (0) 20 3829 6970 Tel: +44 (0) 20 7408 4090
Panmure Liberum (Joint Broker) Investec Bank plc (Joint Broker)
Edward Mansfield Virginia Bull
William King Carlton Nelson
Tel : +44 (0) 20 3100 2222 Tel: +44 (0) 20 7597 4000
Alma (Financial Public Relations)
Sam Modlin
Rebecca Sanders-Hewett
Joe Pederzolli
Sarah Peters
Tel: +44 (0) 20 3405 0205
judges@almastrategic.com (mailto:judges@almastrategic.com)
Notes to editors:
Judges Scientific plc (AIM: JDG), is a group focused on acquiring and
developing companies in the scientific instrument sector. The Group consists
of 25 businesses acquired since 2005.
The acquired companies are primarily UK-based with products sold worldwide to
a diverse range of markets including higher education institutions, scientific
research facilities, manufacturers, and regulatory authorities. The UK is
a recognised centre of excellence for scientific instruments. The Group has
received five Queen's Awards for Innovation and Export.
The Group's companies predominantly operate in global niche markets, with long
term growth fundamentals and resilient margins.
Judges Scientific maintains a policy of selectively acquiring businesses that
generate sustainable profits and cash. Shareholder returns are created
through the reduction of debt, organic growth, and dividends.
For further information, please visit www.judges.uk.com
(http://www.judges.uk.com)
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name David Cicurel
2 Reason for the notification
a) Position/status Non-Executive Chair
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Judges Scientific plc
b) LEI 2138004EXWWPTW1JOL31
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares in Judges Scientific plc
Identification code
GB0032398678
b) Nature of the transaction Gift beneficial interest in 4,000 Ordinary Shares to the Charity
c) Price(s) and volume(s)
Price(s) Volume(s)
4,300p 4,000
d) Aggregated information N/A (single transaction)
- Aggregated volume
- Price
e) Date of the transaction 01/04/2026
f) Place of the transaction Outside a trading venue
d)
Aggregated information
- Aggregated volume
- Price
N/A (single transaction)
e)
Date of the transaction
01/04/2026
f)
Place of the transaction
Outside a trading venue
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBCGDSCXGDGLB
Copyright 2019 Regulatory News Service, all rights reserved